2014
DOI: 10.1016/j.euroneuro.2013.06.007
|View full text |Cite
|
Sign up to set email alerts
|

The motivation and pleasure dimension of negative symptoms: Neural substrates and behavioral outputs

Abstract: A range of emotional and motivation impairments have long been clinically documented in people with schizophrenia, and there has been a resurgence of interest in understanding the psychological and neural mechanisms of the so-called “negative symptoms” in schizophrenia, given their lack of treatment responsiveness and their role in constraining function and life satisfaction in this illness. Negative symptoms comprise two domains, with the first covering diminished motivation and pleasure across a range of lif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
215
3
2

Year Published

2015
2015
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 289 publications
(231 citation statements)
references
References 152 publications
11
215
3
2
Order By: Relevance
“…We have summarised this body of research in a single anticipatory deficit model of ANS (Figure 1). The model is consistent with neurophysiological studies, suggesting changes in the neural pathways mediating 'wanting', while 'hedonic' neural pathways, and consummatory pleasure (the immediate experiential pleasure of a primary reinforcer) are unaffected (Barch and Dowd, 2010;Kring and Barch, 2014). This consensus suggests focusing interventions on the difference between what is anticipated, and what is likely to be experienced, addressing both anticipatory cognitions and affective pre-experience.…”
Section: Psychological Models Of Negative Symptoms In Psychosissupporting
confidence: 77%
See 1 more Smart Citation
“…We have summarised this body of research in a single anticipatory deficit model of ANS (Figure 1). The model is consistent with neurophysiological studies, suggesting changes in the neural pathways mediating 'wanting', while 'hedonic' neural pathways, and consummatory pleasure (the immediate experiential pleasure of a primary reinforcer) are unaffected (Barch and Dowd, 2010;Kring and Barch, 2014). This consensus suggests focusing interventions on the difference between what is anticipated, and what is likely to be experienced, addressing both anticipatory cognitions and affective pre-experience.…”
Section: Psychological Models Of Negative Symptoms In Psychosissupporting
confidence: 77%
“…The anticipatory deficit in ANS can be conceptualised as the absence of a required bridge between present stasis and future action: in neurophysiological terms, the dopaminergic fronto-striatal pathways through which goal-directed behaviours are hypothesised to be formulated, enacted, and evaluated (Kring and Barch, 2014). If a person is not able to anticipate that a proposed action will bring pleasure or success (i.e.…”
Section: Rationale and Hypothesesmentioning
confidence: 99%
“…One factor is referred to as diminished expression, comprising blunted affect and alogia. The other factor is referred to as diminished motivation and pleasure, or apathy, and comprises asociality, anhedonia and avolition (Kring and Barch, 2014;Strauss et al, 2012). This distinction might allow a more differentiated approach in the search of underlying pathophysiological mechanisms (Blanchard and Cohen, 2006;Foussias and Remington, 2010;Liemburg et al, 2013;Messinger et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Functional MRI experiments probing reward anticipation in the ventral striatum with MID tasks reveal decreased striatal activation in drug-naïve and unmedicated schizophrenia patients Hägele et al, 2015;Juckel et al, 2006b) as well as in participants at high clinical risk for psychosis (Juckel et al, 2012;Wotruba et al, 2014). The degree of reduced reward anticipation is linked to symptom severity (Juckel et al, 2006a;Kring and Barch, 2014;Nielsen et al, 2012) and altered dopamine activity, as suggested by the observation that treatment with atypical antipsychotics partially normalizes ventral striatal dysfunction in schizophrenia (Nielsen et al, 2012;Walter et al, 2009). …”
Section: Reward Anticipation Is Reduced In Schizophreniamentioning
confidence: 98%